“phenylketonuria” Archives

in
Entry Author Date Location
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More 03/13/20 National
Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans 01/13/20 Boston
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D 06/12/19 Boston
LogicBio Prices IPO Below Range, Raising $70M to Test Gene Therapy 10/19/18 Boston
Rubius Upsizes IPO and Hauls in $241M for Red Blood Cell Therapies 07/18/18 Boston
No Data Yet, But Homology Upsizes IPO and Raises $144M 03/28/18 Boston
Unum, Homology Plan IPOs, as Unum Reveals Two Patient Deaths 03/05/18 Boston
Rubius Adds $120M to Ready Tests of Red Blood Cells as Drug Carriers 06/21/17 Boston
BioMarin Heads to FDA With Mixed Data For Rare Disease Drug 03/21/16 San Francisco
Synlogic Nabs $40M, Prepares To Put Modified Microbes Into Patients 02/17/16 Boston
Rubius Aims To Turn Red Blood Cells Into Engineered Drug Carriers 12/09/15 Boston
Five Takeaways From “Boston’s Life Science Disruptors” 10/02/15 Boston
Ex-Pfizer Exec Gutierrez-Ramos to Lead Synlogic’s “Smart Bug” Plan 05/21/15 Boston
West Coast Biotech Roundup: Ebola, Immunotherapy, Avalon & More 09/26/14 San Francisco
Flagship’s Pronutria Emerges to Make Medicines and Medical Foods 10/22/13 Boston
EnVivo, Biogen, Momenta, & Other Boston-Area Life Sciences Newsmakers 12/09/11 Boston
Cambrooke Foods Aims to Help Nourish Patients with Metabolic Disorders 12/08/11 Boston
BioMarin Scraps Muscular Dystrophy Drug 08/02/10 San Francisco
Page 1 of 1